Dystrophinopathy patient data as a guide to interpretation of pregestational female population screening for DMD gene variants
Authors:
- 20 November 2024
- journal article
- research article
- Published by Springer Nature in neurogenetics
- Vol. 26 (1) , 1-6
Abstract
Pregestational population screening of healthy females for copy number variants in DMD gene has raised numerous challenges regarding the interpretation and disclosure of these findings. Our objective was to analyze data from a local dystrophinopathy patient database, in comparison to population screening results. Utilizing the “Little steps” association registry for children with dystrophinopathy, we classified genetic findings (out-of-frame, in-frame, or difficult-to-predict) in 231 DMD and 90 BMD male patients. A comparison was made with a previously published cohort of 162 female carriers identified through population screening. Duplications classified as “difficult to predict” were absent in DMD/BMD patients, as opposed to 45.1% of women analyzed in the scope of population screening (p < 0.0001). While the distribution of deletions did not differ between the groups, significantly higher proportion of duplications initiated at the proximal hot spot in the DMD/BMD cohort (87.1%), vs. only 11.7% in women analyzed through population screening (p = 0.0038). Notably, duplications initiating in the dp427c promoter area were noted only in the latter cohort (n = 62). Local databases of dystrophinopathy patients can facilitate analysis and reporting of pregestational female population screening results. These conclusions facilitate future introductions of population screening genetic tests for diseases with variable presentation.Keywords
This publication has 8 references indexed in Scilit:
- Lessons learned from the first national population-based genetic carrier-screening program for Duchenne muscular dystrophyGenetics in Medicine, 2023
- 263rd ENMC International Workshop: Focus on female carriers of dystrophinopathy: refining recommendations for prevention, diagnosis, surveillance, and treatment. Hoofddorp, The Netherlands, 13-15 May 2022Neuromuscular Disorders, 2023
- Large scale population screening for Duchenne muscular dystrophy—Predictable and unpredictable challengesPrenatal Diagnosis, 2022
- Genotype–Phenotype Correlations in Duchenne and Becker Muscular Dystrophy Patients from the Canadian Neuromuscular Disease RegistryJournal of Personalized Medicine, 2020
- Muscle biopsies in clinical trials for Duchenne muscular dystrophy – Patients’ and caregivers’ perspectiveNeuromuscular Disorders, 2019
- Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Confirmed by Multiplex Ligation-Dependent Probe Amplification: Genotype-Phenotype Correlation in a Large CohortJournal of Clinical Neurology, 2017
- DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype CorrelationsPLOS ONE, 2015
- Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading‐frame ruleMuscle & Nerve, 2006